Spatiotemporal immunomodulation with programmable biomaterials to promote musculoskeletal tissue regeneration.

Abstract

Musculoskeletal disorders (MSDs), encompassing a variety of degenerative and inflammatory conditions, are frequently associated with immune dysregulation. This dysregulation can result in significant pathological changes within the tissue microenvironment, including abnormal inflammatory responses, biochemical and biophysical imbalances, and epigenetic modifications. Such alterations can serve as endogenous stimuli for targeted therapeutic interventions in MSDs. This review introduces the innovative concept of programmable biomaterials, which are designed to respond dynamically to specific endogenous signals within the tissue microenvironment. A comprehensive overview of the pathogenesis of several key MSDs is provided, detailing the disease-specific endogenous signals that can be exploited to enhance the functionality of programmable biomaterials. Central to the discussion is the importance of spatiotemporal immunomodulation in the treatment of various MSDs. Programmable biomaterials are categorized based on their mechanisms of endogenous responsiveness, highlighting their potential applications in clinical settings. Future directions for the design of advanced programmable biomaterials are explored, emphasizing their capacity to transform existing therapeutic strategies for MSDs. This emerging field holds great promise for improving patient outcomes by tailoring treatment approaches to the intricate biological cues present in musculoskeletal tissues.